Last edition
News about Regulation
Eris Lifesciences Secures ANVISA Approval for Sterile Injectable Facility in Ahmedabad
Eris Lifesciences has received Anvisa approval for one of its sterile injectable manufacturing facilities in Ahmedabad, enabling entry into the Brazilian market.
Regulation | 26/08/2025 | By Mrinmoy Dey | 330
CDSCO Cancels Import Registration of Mediderma Products Over Excess Salicylic Acid
The Central Drugs Standard Control Organisation (CDSCO) has cancelled the import registration of certain skincare products from US-based Mediderma after finding salicylic acid levels far above the permissible limit.
Regulation | 26/08/2025 | By Dineshwori | 479
Pharmexcil Calls for GST Parity on APIs and Formulations to Boost Pharma Efficiency
The Pharmaceuticals Export Promotion Council of India (Pharmexcil) has called for harmonising GST rates on both active pharmaceutical ingredients (APIs) and finished formulations to streamline compliance and ease financial strain.
Regulation | 26/08/2025 | By Darshana | 358
Eris Lifesciences Secures ANVISA Approval for its Manufacturing Unit in Ahmedabad
Eris Lifesciences has received ANVISA approval for a manufacturing unit at its Ahmedabad campus, paving the way for entry into Brazil, South America’s largest pharmaceutical market.
Regulation | 25/08/2025 | By Mrinmoy Dey | 437
PLI Scheme Brings Down Rare Disease Treatment Costs from Crores to Lakhs: Pharma Secretary
The Production Linked Incentive (PLI) Scheme for pharmaceuticals has significantly reduced the cost of treating rare diseases in India, bringing expenses down from crores to just a few lakhs, said Amit Agrawal, Secretary, Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers.
Regulation | 22/08/2025 | By Dineshwori | 175
Eli Lilly has voiced opposition to proposed tariffs on pharmaceutical products, cautioning that such measures could increase costs, limit patient access, and weaken US leadership in biopharmaceutical innovation.
Regulation | 16/08/2025 | By Dineshwori | 234
India Launches SHRESTH to Strengthen State Drug Regulatory Systems
The initiative, proposed by the Central Drugs Standard Control Organization (CDSCO), aims to drive improvements in the performance of state drug regulatory authorities across India, ensuring drug safety and quality standards are consistently met.
<br />
Regulation | 13/08/2025 | By Dineshwori | 348
The Pharmaceuticals Export Promotion Council of India (Pharmexcil) has called on all member companies exporting formulations to Zambia to comply with the country's new pre-shipment regulations aimed at curbing the import of counterfeit and substandard medicines.
Regulation | 12/08/2025 | By Dineshwori | 229
Paracetamol Not Banned in India, Clarifies Union Minister Anupriya Patel
Union Minister of State for Chemicals and Fertilizers Anupriya Patel has clarified on social media rumours regarding a ban on paracetamol and other common medicines.
Regulation | 06/08/2025 | By Dineshwori | 511
In a bid to ease regulatory compliance and enhance the ease of doing business, the Central Drugs Standard Control Organisation (CDSCO) will launch a new online system for issuing No Objection Certificates (NOCs) for bulk drug imports intended for non-medicinal use.
Regulation | 05/08/2025 | By Darshana | 771
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy